Axsome Therapeutics (AXSM) News Today $116.49 +4.28 (+3.81%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$116.25 -0.24 (-0.21%) As of 07:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Avidity Partners Management LP Cuts Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Avidity Partners Management LP reduced its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 36.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 188,000 shares of the company's stock after selling 108,100 shares during theMay 6 at 7:39 AM | marketbeat.comBVF Inc. IL Grows Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)BVF Inc. IL grew its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 32.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,388,064 shares of the company's stock afterMay 6 at 7:30 AM | marketbeat.comBellevue Group AG Sells 248,251 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)Bellevue Group AG cut its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 67.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 118,930 shares of the company's stock after selling 248,251 sMay 6 at 6:39 AM | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) is Alethea Capital Management LLC's Largest PositionAlethea Capital Management LLC lessened its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 0.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 734,317 shares of the company's stockMay 6 at 5:42 AM | marketbeat.comAXSM FY2025 EPS Estimate Increased by Cantor FitzgeraldAxsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) - Investment analysts at Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for Axsome Therapeutics in a report issued on Thursday, May 1st. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will earn ($May 6 at 2:50 AM | marketbeat.comThe three-year returns have been enviable for Axsome Therapeutics (NASDAQ:AXSM) shareholders despite underlying losses increasingMay 5 at 5:56 PM | finance.yahoo.comAxsome Therapeutics, Inc. (AXSM) Q1 2025 Earnings Call TranscriptMay 5 at 12:04 PM | seekingalpha.comAxsome Therapeutics, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 5 at 9:55 AM | seekingalpha.comAxsome Therapeutics beats Q1 expectations, shares riseMay 5 at 7:55 AM | investing.comAxsome Therapeutics Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 5 at 7:00 AM | globenewswire.comCantor Fitzgerald Issues Positive Estimate for AXSM EarningsMay 5 at 2:53 AM | americanbankingnews.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Short Interest UpdateAxsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 4,420,000 shares, a drop of 14.2% from the March 31st total of 5,150,000 shares. Approximately 11.7% of the shares of the stock are short sold. Based on an average trading volume of 891,700 shares, the short-interest ratio is presently 5.0 days.May 5 at 2:53 AM | marketbeat.comAlly Bridge Group NY LLC Invests $5.64 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Ally Bridge Group NY LLC purchased a new stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 66,661 shares of the company's stock, valued at aMay 4 at 7:45 AM | marketbeat.comBoxer Capital Management LLC Buys New Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Boxer Capital Management LLC purchased a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 470,000 shares of the company's stock, valued at approximaMay 4 at 6:25 AM | marketbeat.comPDT Partners LLC Sells 7,506 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)PDT Partners LLC trimmed its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 64.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,195 shares of the company's stock after selling 7,506 shares durinMay 4 at 5:16 AM | marketbeat.comFirst Trust Advisors LP Raises Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)First Trust Advisors LP boosted its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 26.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,580 shMay 4 at 3:44 AM | marketbeat.comAxsome Therapeutics (AXSM) Expected to Announce Quarterly Earnings on MondayMay 4 at 2:09 AM | americanbankingnews.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by Tower Research Capital LLC TRCTower Research Capital LLC TRC raised its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 612.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,573 shares of the company's stock after buying an additioMay 3 at 4:11 AM | marketbeat.comVoya Investment Management LLC Grows Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Voya Investment Management LLC increased its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 8.7% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 102,742 shares of the company's stock after buying an additionalMay 2, 2025 | marketbeat.comAxsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $193.00 at Royal Bank of CanadaRoyal Bank of Canada boosted their price target on Axsome Therapeutics from $190.00 to $193.00 and gave the stock an "outperform" rating in a research report on Tuesday.May 1, 2025 | marketbeat.comAxsome Therapeutics and Mental Health America (MHA) Join Voices to Highlight Mental Health MonthMay 1, 2025 | financialpost.comAxsome Therapeutics and Mental Health America (MHA) Join Voices to Highlight Mental Health MonthMay 1, 2025 | globenewswire.comAdage Capital Partners GP L.L.C. Sells 465,000 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)Adage Capital Partners GP L.L.C. decreased its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 88.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 60,000 shares of the company's stock afteMay 1, 2025 | marketbeat.comAxsome Therapeutics (AXSM) Expected to Post Quarterly Earnings on MondayAxsome Therapeutics (NASDAQ:AXSM) will be releasing its Q1 2025 earnings before the market opens on Monday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-5-axsome-therapeutics-inc-stock/)April 30, 2025 | marketbeat.comTri Locum Partners LP Has $21.13 Million Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Tri Locum Partners LP boosted its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 172.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 249,769 shares of the company's stock after buying an additional 158,048 shares duApril 29, 2025 | marketbeat.comCanada Pension Plan Investment Board Makes New $347,000 Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Canada Pension Plan Investment Board purchased a new stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 4,100 shares of the company's stoApril 28, 2025 | marketbeat.comEnvestnet Asset Management Inc. Increases Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Envestnet Asset Management Inc. raised its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 74.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 35,129 shares of the compApril 28, 2025 | marketbeat.comBrokerages Set Axsome Therapeutics, Inc. (NASDAQ:AXSM) Target Price at $169.80April 28, 2025 | americanbankingnews.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Rating of "Buy" by BrokeragesShares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) have been given an average rating of "Buy" by the sixteen ratings firms that are presently covering the stock, MarketBeat reports. Sixteen analysts have rated the stock with a buy rating. The average 1 year price target among analApril 27, 2025 | marketbeat.comSeven Springs Wealth Group LLC Invests $339,000 in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Seven Springs Wealth Group LLC purchased a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 4,005 shares ofApril 26, 2025 | marketbeat.comBarclays PLC Purchases 36,203 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)Barclays PLC lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 58.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 97,988 shares of the company's stock aApril 26, 2025 | marketbeat.comHood River Capital Management LLC Has $54.56 Million Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Hood River Capital Management LLC grew its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 3.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 644,785 shares of the company's stock after puApril 25, 2025 | marketbeat.comMarshall Wace LLP Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Marshall Wace LLP purchased a new position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 127,097 shares of the company's stock, vaApril 24, 2025 | marketbeat.comRaymond James Financial Inc. Purchases Shares of 174,586 Axsome Therapeutics, Inc. (NASDAQ:AXSM)Raymond James Financial Inc. acquired a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 174,586 shares of the company's stock, valued at approximApril 23, 2025 | marketbeat.comAxsome Therapeutics to Participate in Upcoming Investor ConferencesApril 22, 2025 | globenewswire.comRussell Investments Group Ltd. Boosts Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Russell Investments Group Ltd. increased its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 1,815.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,437 shares of tApril 21, 2025 | marketbeat.com1492 Capital Management LLC Purchases New Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)1492 Capital Management LLC acquired a new position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 11,385 shares of the company's stApril 20, 2025 | marketbeat.comQ1 Earnings Estimate for AXSM Issued By Leerink PartnrsAxsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) - Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for Axsome Therapeutics in a research report issued on Sunday, April 13th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post earnings of ($1April 18, 2025 | marketbeat.comXTX Topco Ltd Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM)XTX Topco Ltd purchased a new stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 13,151 shares of the company's stock, valued at approximately $1,113,000. A number of other institutional investoApril 18, 2025 | marketbeat.comWhat is Leerink Partnrs' Estimate for AXSM FY2027 Earnings?Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) - Investment analysts at Leerink Partnrs increased their FY2027 EPS estimates for shares of Axsome Therapeutics in a research report issued to clients and investors on Sunday, April 13th. Leerink Partnrs analyst M. Goodman now anticipates thatApril 17, 2025 | marketbeat.comAffinity Asset Advisors LLC Sells 5,000 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)Affinity Asset Advisors LLC reduced its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 6.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 75,000 shares of the company's stock after selling 5,000 shares during the quarter. AffApril 17, 2025 | marketbeat.comKuehn Law Encourages Investors of Five Below, Inc. to Contact Law FirmApril 16, 2025 | globenewswire.comKuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law FirmApril 16, 2025 | globenewswire.comInvesco Ltd. Boosts Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Invesco Ltd. grew its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 10.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 692,464 shares of the company's stock after buying anApril 16, 2025 | marketbeat.comLPL Financial LLC Raises Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)LPL Financial LLC raised its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 47.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 24,209 shares of the company's stock after buying an additioApril 16, 2025 | marketbeat.comThis Little-Known Stock Could Be One of the Best Recession-Proof Investments NowApril 15, 2025 | msn.comGranite Investment Partners LLC Buys Shares of 91,649 Axsome Therapeutics, Inc. (NASDAQ:AXSM)Granite Investment Partners LLC purchased a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 91,649 shares of the company's stock, valued at approximately $7,754,April 15, 2025 | marketbeat.comAxsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Kennedy Capital Management LLCKennedy Capital Management LLC lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 95.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 37,941 shares of the coApril 15, 2025 | marketbeat.comAlliancebernstein L.P. Sells 78,388 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM)Alliancebernstein L.P. lessened its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 62.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,590 shares of the company's stApril 15, 2025 | marketbeat.comGeode Capital Management LLC Boosts Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM)Geode Capital Management LLC boosted its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 0.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 912,538 shares of the company's stock after buying an aApril 14, 2025 | marketbeat.com Get Axsome Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter. Email Address AXSM Media Mentions By Week AXSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXSM News Sentiment▼1.160.72▲Average Medical News Sentiment AXSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXSM Articles This Week▼2310▲AXSM Articles Average Week Get Axsome Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SMMT News TEVA News ITCI News GMAB News RDY News MRNA News ASND News VTRS News QGEN News ROIV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXSM) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Axsome Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Axsome Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AXSM Stock Free AXSM Stock Alerts